Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             159 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgement to reviewers - 2013 MurdacaGiuseppe.Murdaca@unige.it, Giuseppe
2014
53-54 1 p. 1-
1 p.
artikel
2 Acknowledgement to reviewers - 2014 2015
53-54 1 p. 1-
1 p.
artikel
3 Acromegaly and aging: A comparative cross-sectional study Hatipoglu, Esra
2015
53-54 1 p. 47-52
6 p.
artikel
4 Actions and interactions of the IGF system in Alzheimer’s disease: review and hypotheses Lackey, Brett R.
2000
53-54 1 p. 1-13
13 p.
artikel
5 A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide Holt, Richard I.G.
2009
53-54 1 p. 43-50
8 p.
artikel
6 Aims & Scope/Editorial Board 2010
53-54 1 p. i-
1 p.
artikel
7 Aims & Scope/Editorial Board 2003
53-54 1 p. i-
1 p.
artikel
8 Aims & Scope/Editorial Board 2009
53-54 1 p. i-
1 p.
artikel
9 Aims & Scope/Editorial Board 2006
53-54 1 p. i-
1 p.
artikel
10 Aims & Scope/Editorial Board 2008
53-54 1 p. i-
1 p.
artikel
11 Aims & Scope/Editorial Board 2007
53-54 1 p. i-
1 p.
artikel
12 A new radioimmunoassay to measure rat insulin-like growth factor binding protein-4 (IGFBP-4) in serum, wound fluid and conditioned media Chelius, D.
2001
53-54 1 p. 49-57
9 p.
artikel
13 Are the metabolic effects of GH and IGF-I separable? Mauras, Nelly
2005
53-54 1 p. 19-27
9 p.
artikel
14 Biological effects of growth hormone on carbohydrate and lipid metabolism Vijayakumar, Archana
2010
53-54 1 p. 1-7
7 p.
artikel
15 Cell-type specific expression of IGF-1R in porcine islet cells Schweiger, Markus
2005
53-54 1 p. 33-38
6 p.
artikel
16 Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults Wieringa, G.
2000
53-54 1 p. 14-19
6 p.
artikel
17 Characterization and partial purification of the insulin-like growth factor (IGF)-dependent IGF binding protein-4-specific protease from human fibroblast conditioned media Lawrence, James B
1999
53-54 1 p. 25-34
10 p.
artikel
18 Clinical pharmacological aspects of growth hormone administration Laursen, Torben
2004
53-54 1 p. 16-44
29 p.
artikel
19 Daily energy balance in growth hormone receptor/binding protein (GHR −/−) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency Longo, Kenneth A.
2010
53-54 1 p. 73-79
7 p.
artikel
20 Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction Koutsaki, Maria
2011
53-54 1 p. 31-36
6 p.
artikel
21 Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR Henderson, S.T.
2015
53-54 1 p. 20-27
8 p.
artikel
22 Developmental changes in insulin-like growth factor (IGF)-I and -II mRNA abundance in extra-embryonic membranes and small intestine of avian embryos Karcher, D.M.
2009
53-54 1 p. 31-42
12 p.
artikel
23 Developmental changes in the mRNA levels of IGF-I and its related genes in the reproductive organs of Japanese quail (Coturnix coturnix japonica) Fu, Z.
2001
53-54 1 p. 24-33
10 p.
artikel
24 Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins Feldmann, Berit
2000
53-54 1 p. 53-59
7 p.
artikel
25 Diagnosis of adult GH deficiency Ghigo, E.
2008
53-54 1 p. 1-16
16 p.
artikel
26 Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice Lahm, Harald
2002
53-54 1 p. 69-79
11 p.
artikel
27 Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults Hoeck, Hans C.
1999
53-54 1 p. 18-24
7 p.
artikel
28 Differential effects of fluoride and insulin-like growth factor I on sodium-dependent alanine and phosphate transport in a human osteoblast-like cell line Veldman, Ch.M.
1998
53-54 1 p. 55-63
9 p.
artikel
29 Differential expression of renal growth hormone receptor and its binding protein in experimental diabetes mellitus Landau, D.
1998
53-54 1 p. 39-45
7 p.
artikel
30 Differential induction of transcription factors and expression of milk protein genes by prolactin and growth hormone in the mammary gland of rabbits Malewski, T.
2002
53-54 1 p. 41-53
13 p.
artikel
31 Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes Høst, Christian
2010
53-54 1 p. 26-30
5 p.
artikel
32 Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity Stanley, Takara L.
2014
53-54 1 p. 10-15
6 p.
artikel
33 Early programming of the IGF-I axis: Negative association between IGF-I in infancy and late adolescence in a 17-year longitudinal follow-up study of healthy subjects Larnkjaer, Anni
2009
53-54 1 p. 82-86
5 p.
artikel
34 Editorial Le Roith, Derek
1998
53-54 1 p. 1-2
2 p.
artikel
35 Editorial board 2004
53-54 1 p. i-
1 p.
artikel
36 Editorial Board 1998
53-54 1 p. CO2-
1 p.
artikel
37 Editorial board 2005
53-54 1 p. i-
1 p.
artikel
38 Editorial Board 2012
53-54 1 p. i-
1 p.
artikel
39 Editorial Board 2015
53-54 1 p. i-
1 p.
artikel
40 Editorial Board 2011
53-54 1 p. i-
1 p.
artikel
41 Editorial Board 2014
53-54 1 p. i-
1 p.
artikel
42 Effect of capsaicin on plasma and tissue levels of insulin-like growth factor-I in spontaneously hypertensive rats Harada, Naoaki
2008
53-54 1 p. 75-81
7 p.
artikel
43 Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis Clifton, Vicki L.
2010
53-54 1 p. 39-48
10 p.
artikel
44 Effects of bench step exercise on arterial stiffness in post-menopausal women: Contribution of IGF-1 bioactivity and nitric oxide production Ohta, Masanori
2012
53-54 1 p. 36-41
6 p.
artikel
45 Effects of IGFBP-1 and IGFBP-2 and their fragments on migration and IGF-induced proliferation of human dermal fibroblasts Brandt, Katrin
2015
53-54 1 p. 34-40
7 p.
artikel
46 Effects of the regulation of follistatin mRNA expression by IGF-1 in duck (Anas platyrhynchos) skeletal muscle Liu, Hehe
2014
53-54 1 p. 35-41
7 p.
artikel
47 Effects of thyroid hormone on the GH signal transduction pathway Ocaranza, Paula
2014
53-54 1 p. 42-46
5 p.
artikel
48 Endocrine and metabolic aspects of adult Prader–Willi syndrome with special emphasis on the effect of growth hormone treatment Höybye, Charlotte
2004
53-54 1 p. 1-15
15 p.
artikel
49 Endoplasmic reticulum calcium storage and release in cells expressing misfolded growth hormone Graves, Thomas K.
2003
53-54 1 p. 36-43
8 p.
artikel
50 Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: A placebo controlled study Cakir, Ilkay
2012
53-54 1 p. 17-21
5 p.
artikel
51 Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly Tanriverdi, F.
2009
53-54 1 p. 24-30
7 p.
artikel
52 Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults Nørrelund, Helene
1999
53-54 1 p. 52-60
9 p.
artikel
53 Expression of GH receptor, IGF-I receptor and IGF-I mRNA in the kidney and liver of rats recovering from unilateral renal ischemia Matejka, G.L.
1998
53-54 1 p. 77-82
6 p.
artikel
54 Expression of ghrelin receptor, GHSR-1a, and its functional role in the porcine ovarian follicles Rak, Agnieszka
2009
53-54 1 p. 68-76
9 p.
artikel
55 Free insulin-like growth factor-I and cognitive function in older persons living in community Landi, Francesco
2007
53-54 1 p. 58-66
9 p.
artikel
56 Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: Effects on glucose control, plasma IGF-I and glutamine Duška, František
2008
53-54 1 p. 82-87
6 p.
artikel
57 Glucagon and GLP-1 stimulate IGFBP-1 secretion in Hep G2 cells without effect on IGFBP-1 mRNA Hilding, Agneta
2002
53-54 1 p. 60-68
9 p.
artikel
58 Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat Thomas, G.B.
2000
53-54 1 p. 45-52
8 p.
artikel
59 Glucose homeostasis in adults with Prader–Willi syndrome during treatment with growth hormone: Results from a 12-month prospective study Jørgensen, Anders Palmstrøm
2014
53-54 1 p. 16-21
6 p.
artikel
60 Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement Spina, Luciana Diniz Carneiro
2004
53-54 1 p. 45-51
7 p.
artikel
61 Growth hormone- and pressure overload-induced cardiac hypertrophy evoke different responses to ischemia-reperfusion and mechanical stretch Strömer, Hinrik
2006
53-54 1 p. 29-40
12 p.
artikel
62 Growth hormone and the somatopause 1999
53-54 1 p. 3-10
8 p.
artikel
63 Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response Florkowski, C.M.
1999
53-54 1 p. 35-40
6 p.
artikel
64 Growth hormone (GH) and estradiol regulation of membrane-associated GH binding protein and GH receptors in GH releasing hormone transgenic mice González, L.
2001
53-54 1 p. 34-40
7 p.
artikel
65 Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response Svensson, Johan
2007
53-54 1 p. 67-76
10 p.
artikel
66 Growth hormone replacement therapy for adults: Into the new millennium Simpson, Helen
2002
53-54 1 p. 1-33
33 p.
artikel
67 Growth hormone secretagogues:mechanism of action and use in aging Fuh, V.L.
1998
53-54 1 p. 13-20
8 p.
artikel
68 Growth Hormone Society Research Fellowships 2008 2008
53-54 1 p. iv-
1 p.
artikel
69 Growth Hormone Society Research Fellowships 2006 2006
53-54 1 p. 65-
1 p.
artikel
70 Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA Lieskovska, Jaroslava
2003
53-54 1 p. 26-35
10 p.
artikel
71 GSPα mutations in Mexican patients with acromegaly: potential impact on long term prognosis Mendoza, Victoria
2005
53-54 1 p. 28-32
5 p.
artikel
72 Heat acclimation decreases the growth hormone response to acute constant-load exercise in the heat Ööpik, Vahur
2014
53-54 1 p. 2-9
8 p.
artikel
73 Hepatic expression of growth hormone receptor/binding protein and insulin-like growth factor I genes in uremic rats. Influence of nutritional deficit Martı́nez, Venancio
1999
53-54 1 p. 61-68
8 p.
artikel
74 High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization Parkinson, Craig
2004
53-54 1 p. 59-65
7 p.
artikel
75 Hormonal influences of early postnatal indomethacin and ibuprofen in neonatal rats Gebrekristos, Bisrat
2010
53-54 1 p. 31-38
8 p.
artikel
76 IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis Fang, Peng
2008
53-54 1 p. 38-46
9 p.
artikel
77 IGF-I but not the IGF-I variant Long R3IGF-I increases serum IGFBP-3 in adolescent monkeys Wilson, M.E.
2000
53-54 1 p. 37-44
8 p.
artikel
78 Impact of the growth hormone replacement on bone status in growth hormone deficient adults Kužma, M.
2014
53-54 1 p. 22-28
7 p.
artikel
79 Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly Bayram, Fahri
2014
53-54 1 p. 29-34
6 p.
artikel
80 Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast α5β1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures Irwin, J.C.
1998
53-54 1 p. 21-31
11 p.
artikel
81 Insulin-like growth factor I enhances collagen synthesis in engineered human tendon tissue Herchenhan, Andreas
2015
53-54 1 p. 13-19
7 p.
artikel
82 Insulin-like growth factor-I (IGF-I) serum concentrations in healthy children and adolescents: Relationship to level of contamination by DDT-derivative pesticides Zumbado, Manuel
2010
53-54 1 p. 63-67
5 p.
artikel
83 Insulin-like growth factor I receptors on blood cells: their relationship to circulating total and “free” IGF-I, IGFBP-1, IGFBP-3 and insulin levels in healthy subjects Janssen, J.A.M.J.L.
1998
53-54 1 p. 47-54
8 p.
artikel
84 In vivo evaluation of a novel, orally bioavailable, small molecule growth hormone receptor antagonist Rosengren, Linda
2007
53-54 1 p. 47-53
7 p.
artikel
85 Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? Yuen, Kevin C.J.
2007
53-54 1 p. 82-88
7 p.
artikel
86 Judson J. Van Wyk, M.D.: his life and legacy D’Ercole, A. Joseph
2005
53-54 1 p. 1-3
3 p.
artikel
87 Kyolic® and Pycnogenol® increase human growth hormone secretion in genetically-engineered keratinocytes Buz'Zard, Amber R
2002
53-54 1 p. 34-40
7 p.
artikel
88 Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48weeks of physical training Gregory, Sara M.
2011
53-54 1 p. 51-56
6 p.
artikel
89 L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl- L-arginine in healthy men Fisker, Sanne
1999
53-54 1 p. 69-73
5 p.
artikel
90 Long-term administration of adrenocorticotropin modulates the expression of IGF-I and TGF-β 1mRNAs in the rat adrenal cortex Otsuka, Fumio
1999
53-54 1 p. 41-51
11 p.
artikel
91 Long-term IGF-I treatment of children with Laron syndrome increases adiposity Laron, Zvi
2006
53-54 1 p. 61-64
4 p.
artikel
92 Management and interpretation of heterogeneous observational data: Using insulin-like growth factor-I data from the NordiNet® International Outcome Study Blankenstein, Oliver
2015
53-54 1 p. 41-46
6 p.
artikel
93 Measurement of human growth hormone by immunoassays: Current status, unsolved problems and clinical consequences Bidlingmaier, Martin
2010
53-54 1 p. 19-25
7 p.
artikel
94 Monoclonal antibodies to the carboxy-terminal Ea sequence of pro-insulin-like growth factor-IA (proIGF-IA) recognize proIGF-IA secreted by IM9 B-lymphocytes Wilson, H.E.
2001
53-54 1 p. 10-17
8 p.
artikel
95 Multicentre collaborative study to calibrate IGF-II by bioassay and immunoassay: establishment of the First WHO Reference Reagent Rafferty, B.
2001
53-54 1 p. 18-23
6 p.
artikel
96 Multiple signaling pathways are involved in the regulation of IGF-I receptor inhibition of PTEN-enhanced apoptosis Wu, Yiping
2004
53-54 1 p. 52-58
7 p.
artikel
97 Muscle development, insulin-like growth factor-I and myostatin mRNA levels in chickens selected for increased breast muscle yield Guernec, A
2003
53-54 1 p. 8-18
11 p.
artikel
98 New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: the molecular evolution of IGFs and associated peptides in primates Wallis, Michael
2009
53-54 1 p. 12-23
12 p.
artikel
99 Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells Chen, Xiaoyan
2006
53-54 1 p. 41-48
8 p.
artikel
100 Overexpression of mature insulin-like growth factor (IGF)-II leads to growth arrest in Caco-2 human colon cancer cells Kim, Eun Ji
2005
53-54 1 p. 64-71
8 p.
artikel
101 Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary report Shevah, O.
2007
53-54 1 p. 54-57
4 p.
artikel
102 Peripheral administration of bovine GH regulates the expression of cerebrocortical beta-globin, GABAB receptor 1, and the Lissencephaly-1 protein (LIS-1) in adult hypophysectomized rats Walser, Marion
2011
53-54 1 p. 16-24
9 p.
artikel
103 Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells Yu, J.
1998
53-54 1 p. 65-70
6 p.
artikel
104 Physiology and pathophysiology of growth hormone-binding protein: Methodological and clinical aspects Fisker, Sanne
2006
53-54 1 p. 1-28
28 p.
artikel
105 Placental development and fetal growth in growth hormone-treated ewes Jenkinson, C.M.C.
1999
53-54 1 p. 11-17
7 p.
artikel
106 Placental growth hormone during pregnancy in a growth hormone deficient woman with type 1 diabetes compared to a matching diabetic control group Fuglsang, Jens
2004
53-54 1 p. 66-70
5 p.
artikel
107 Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF–IGFBP axis Koyama, Satomi
2010
53-54 1 p. 55-62
8 p.
artikel
108 Post-transcriptional and post-translational regulation of insulin-like growth factor binding protein-3 and -4 by insulin-like growth factor-I in uterine myometrial cells Huynh, Hung
2000
53-54 1 p. 20-27
8 p.
artikel
109 Potential risks of glucagon stimulation test in elderly people Tavares, Ana Beatriz Winter
2015
53-54 1 p. 53-56
4 p.
artikel
110 Predicting growth in response to growth hormone treatment Ranke, Michael B.
2009
53-54 1 p. 1-11
11 p.
artikel
111 Pregnancy-associated plasma protein-A (PAPP-A): A local regulator of IGF bioavailability through cleavage of IGFBPs Boldt, Henning B.
2007
53-54 1 p. 10-18
9 p.
artikel
112 Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes Ringholm, Lene
2011
53-54 1 p. 25-30
6 p.
artikel
113 Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status Savastano, Silvia
2015
53-54 1 p. 28-33
6 p.
artikel
114 Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats Cool, Johanna C.
2005
53-54 1 p. 72-82
11 p.
artikel
115 Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22–25-kDa proteolytic fragment (1–160) and inhibited by the 16-kDa fragment (1–95) of recombinant human insulin-like growth factor binding protein-3 Angelloz-Nicoud, P.
1998
53-54 1 p. 71-75
5 p.
artikel
116 Proximal tubule overexpression of a locally acting IGF isoform, Igf-1Ea, increases inflammation after ischemic injury Rae, Fiona K.
2012
53-54 1 p. 6-16
11 p.
artikel
117 Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit Hwang, David L.
2008
53-54 1 p. 65-74
10 p.
artikel
118 Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle Shavlakadze, Thea
2005
53-54 1 p. 4-18
15 p.
artikel
119 Reduced growth hormone secretion after cranial irradiation contributes to neurocognitive dysfunction Quik, E.H.
2012
53-54 1 p. 42-47
6 p.
artikel
120 Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling Johansen, T.
2005
53-54 1 p. 55-63
9 p.
artikel
121 Regional distribution and ontogeny of the first exon variants of the rat growth hormone receptor mRNA in the brain and the pituitary gland Nogami, Haruo
2011
53-54 1 p. 11-15
5 p.
artikel
122 Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts Govoni, K.E.
2006
53-54 1 p. 49-56
8 p.
artikel
123 Relationship between GH-induced metabolic changes and changes in body composition: A dose and time course study in GH-deficient adults Burt, Morton G.
2008
53-54 1 p. 55-64
10 p.
artikel
124 Relationship between GH response and glycemic fluctuations in the glucagon stimulation test Giuffrida, Fernando M.A.
2009
53-54 1 p. 77-81
5 p.
artikel
125 Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats Skjærbæk, Christian
1999
53-54 1 p. 74-80
7 p.
artikel
126 Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving rhGH Aperghis, Michael
2009
53-54 1 p. 61-67
7 p.
artikel
127 Serum IGF-I levels are similar in Samoan, Māori and European populations despite differences in body composition Bagg, W.
2006
53-54 1 p. 57-60
4 p.
artikel
128 Serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3) and leptin levels are related to abdominal aortic intima-media thickness in macrosomic newborns Koklu, Esad
2007
53-54 1 p. 26-32
7 p.
artikel
129 Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression Scheinowitz, M.
2003
53-54 1 p. 19-25
7 p.
artikel
130 Short stature and metabolic abnormalities in two sisters with a 7.6-kb GH1 gene deletion Ahmad, Tariq
2011
53-54 1 p. 37-43
7 p.
artikel
131 Short-term changes in growth and urinary growth hormone, insulin-like growth factor-I and markers of bone turnover excretion in healthy prepubertal children Tillmann, V.
2000
53-54 1 p. 28-36
9 p.
artikel
132 Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats López-Menduiña, M.
2012
53-54 1 p. 22-29
8 p.
artikel
133 Temporal and spatial expression of IGF-I and IGFBP-1 during acute-phase response induced by localized inflammation in rats Novosyadlyy, R.
2009
53-54 1 p. 51-60
10 p.
artikel
134 The association between insulin-like growth factor-I and cardiac repolarization Ittermann, Till
2012
53-54 1 p. 1-5
5 p.
artikel
135 The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: Results of the German KIMS database Spielhagen, Christin
2011
53-54 1 p. 1-10
10 p.
artikel
136 The biphasic response of porcine tendon to recombinant porcine growth hormone Choy, Valerie E.
2005
53-54 1 p. 39-46
8 p.
artikel
137 The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration Bauss, F.
2001
53-54 1 p. 1-9
9 p.
artikel
138 The current status of IGF-I assays – A 2009 update Frystyk, Jan
2010
53-54 1 p. 8-18
11 p.
artikel
139 The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment? Crudden, Caitrin
2015
53-54 1 p. 2-12
11 p.
artikel
140 The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats Zhang, Zhi Xin
2012
53-54 1 p. 30-35
6 p.
artikel
141 The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms Svensson, J.
2003
53-54 1 p. 1-7
7 p.
artikel
142 The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects Albert, Stewart G.
2007
53-54 1 p. 19-25
7 p.
artikel
143 The ‘Functional Muscle-Bone Unit’: Probing the relevance of mechanical signals for bone development in children and adolescents Fricke, Oliver
2007
53-54 1 p. 1-9
9 p.
artikel
144 The growth hormone–insulin-like growth factor-I axis in chronic kidney disease Mak, Robert H.
2008
53-54 1 p. 17-25
9 p.
artikel
145 The growth hormone secretagogue hexarelin increases cell proliferation in neurogenic regions of the mouse hippocampus Barlind, Anna
2010
53-54 1 p. 49-54
6 p.
artikel
146 The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis Arwert, L.I.
2005
53-54 1 p. 47-54
8 p.
artikel
147 The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn’s disease: Relations to disease activity and corticosteroid treatment Eivindson, Martin
2007
53-54 1 p. 33-40
8 p.
artikel
148 The molecular basis of growthhormone action Thomas, M.J.
1998
53-54 1 p. 3-11
9 p.
artikel
149 The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects Zdravkovic, M.
2001
53-54 1 p. 41-48
8 p.
artikel
150 The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients Kršek, M
2002
53-54 1 p. 54-59
6 p.
artikel
151 The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models Guo, Ning
2003
53-54 1 p. 44-53
10 p.
artikel
152 The role of the type I insulin-like growth factor receptor (IGF-IR) in glomerular integrity Bridgewater, Darren J.
2008
53-54 1 p. 26-37
12 p.
artikel
153 The secretion of insulin-like growth factor I, prolactin and insulin-like growth factor binding protein 1 by the decidua as predictors of human fetal growth Heffner, L.J.
1998
53-54 1 p. 33-38
6 p.
artikel
154 The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein van Duyvenvoorde, H.A.
2011
53-54 1 p. 44-50
7 p.
artikel
155 6th ESPE Advanced Seminars in Developmental Endocrinology Mullis, Primus E.
2012
53-54 1 p. 48-
1 p.
artikel
156 Thymic hyperplasia in a child treated with growth hormone Polgreen, Lynda
2007
53-54 1 p. 41-46
6 p.
artikel
157 Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene Schayek, Hagit
2010
53-54 1 p. 68-72
5 p.
artikel
158 Two hour mean GH is not superior to basal GH for the follow-up of acromegalic patients treated with Octreotide LAR® Taboada, Giselle Fernandes
2007
53-54 1 p. 77-81
5 p.
artikel
159 Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer’s disease Tei, Eitetsu
2008
53-54 1 p. 47-54
8 p.
artikel
                             159 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland